U.S. Capital Wealth Advisors’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $582K | Sell |
14,352
-350
| -2% | -$14.2K | 0.02% | 562 |
|
|
2025
Q1 | $644K | Sell |
14,702
-5,008
| -25% | -$219K | 0.02% | 525 |
|
|
2024
Q4 | $847K | Sell |
19,710
-2,620
| -12% | -$113K | 0.03% | 451 |
|
|
2024
Q3 | $991K | Buy |
22,330
+4,264
| +24% | +$189K | 0.03% | 354 |
|
|
2024
Q2 | $719K | Buy |
18,066
+5,531
| +44% | +$220K | 0.03% | 389 |
|
|
2024
Q1 | $541K | Buy |
12,535
+635
| +5% | +$27.4K | 0.02% | 454 |
|
|
2023
Q4 | $495K | Buy |
+11,900
| New | +$495K | 0.02% | 455 |
|
|
2023
Q1 | – | Sell |
-1,100
| Closed | -$45K | – | 1550 |
|
|
2022
Q4 | $45K | Buy |
+1,100
| New | +$45K | ﹤0.01% | 912 |
|